Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Correction: ONC212 is a Novel Mitocan Acting Synergistically with Glycolysis Inhibition in Pancreatic Cancer.
Journal: Molecular cancer therapeutics
Published: July 02, 2026
Invited Commentary: Buried Dermal Flap: A Novel Technique for Reducing Comorbidity after Axillary Lymph Node Dissection.
Journal: Journal of the American College of Surgeons
Published: October 27, 2025
Comparison of survival outcomes for patients with Stage III vs de novo Stage IV breast cancer.
Journal: Cancer
Published: January 21, 2025
TRAIL receptor agonist TLY012 in combination with PD-1 inhibition promotes tumor regression in an immune-competent mouse model of pancreatic ductal adenocarcinoma.
Journal: American journal of cancer research
Published: August 29, 2024
Phyllodes Tumors of the Breast: Addressing the Gaps in Consensus Recommendations for Clinical Management.
Journal: Annals of surgical oncology
Published: July 18, 2023
TRAIL agonists rescue mice from radiation-induced lung, skin, or esophageal injury.
Journal: The Journal of clinical investigation
Published: July 07, 2023
GSK-3 Inhibitor Elraglusib Enhances Tumor-Infiltrating Immune Cell Activation in Tumor Biopsies and Synergizes with Anti-PD-L1 in a Murine Model of Colorectal Cancer.
Journal: International journal of molecular sciences
Published: May 27, 2023
GSK-3 inhibitor elraglusib enhances tumor-infiltrating immune cell activation in tumor biopsies and synergizes with anti-PD-L1 in a murine model of colorectal cancer.
Journal: bioRxiv : the preprint server for biology
Published: February 17, 2023
Colorectal cancer extracellular acidosis decreases immune cell killing and is partially ameliorated by pH-modulating agents that modify tumor cell cytokine profiles.
Journal: American journal of cancer research
Published: August 29, 2021
Therapeutic Targeting of Autophagy in Pancreatic Ductal Adenocarcinoma.
Journal: Frontiers in pharmacology
Published: August 01, 2021
Integrating Molecular Biomarker Inputs Into Development and Use of Clinical Cancer Therapeutics.
Journal: Frontiers in pharmacology
Published: July 25, 2021
Last Updated: 09/26/2026